Gout is a painful and potentially disabling form of arthritis that has been recognized since ancient times. Treatments are available to control most cases of gout, but diagnosing this disorder can be difficult, and treatment plans often have to be tailored for each person.
A Journey Begins with the First Step
The ACR Research and Education Foundation (REF) has launched the Action Alliance network, a program that calls on rheumatologists, investigators, and health professionals to join the REF in asking patients and families to be a part of the conversation. The Action Alliance consists of two programs working together: From the Field Speakers Bureau and Patients and Families for Progress.
ACR Partners with Patient Organizations
The ACR met with representatives from 14 patient advocacy organizations in Washington, D.C., to discuss mutual advocacy and legislative objectives.
Optimize Patient Scheduling
Optimizing patient schedules is a continuous process that is critical to physician efficiency and satisfied patients. Taking inventory of the scheduling trends in your practice can have a positive influence on tackling appointment templates, which determines patient flow that affects your revenue.
Where Will Kinase Inhibitors Fit into the RA Treatment Mix?
Presenters at “Looking Ahead to Kinase Inhibition in Rheumatoid Arthritis,” a session here at the 2011 ACR/ARHP Annual Scientific Meeting, delved into some of the big questions that rheumatology faces with kinase inhibitor use.
Susac’s Syndrome: Confusion, Expressive Aphasia, Gait Instability
A 49-year-old man presented to the hospital with confusion, dysarthria, expressive aphasia, and progressive gait instability.
Unexpected Benefits of Bisphosphonates after Hip Fracture
Recent trials show this bisphosphonates can reduce subsequent hip fractures and mortality, while remaining cost effective.
New Diagnostic Criteria for Axial Spondylarthritis
New name and classification criteria for ankylosing spondylitis may help with earlier diagnosis and treatment.
Dermatology Case Review
A 64-year-old man with history of type-II diabetes (well controlled on sitagliptin/metformin), hypertension, and dyslipidemia presents with complaints of an increasingly painful left lower-extremity lesion present for two to three months.
Dermatology Case Answer
A 64-year-old man with history of type-II diabetes (well controlled on sitagliptin/metformin), hypertension, and dyslipidemia presents with complaints of an increasingly painful left lower-extremity lesion present for two to three months.
- « Previous Page
- 1
- …
- 72
- 73
- 74
- 75
- 76
- …
- 86
- Next Page »